Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2007; 98(05): 1148-1150
DOI: 10.1160/TH07-05-0348
DOI: 10.1160/TH07-05-0348
Letters to the Editor
Anticoagulation quality and the risk of recurrence of venous thromboembolism
Authors
Further Information
Publication History
Received
14 May 2007
Accepted after resubmission
15 August 2007
Publication Date:
30 November 2017 (online)
-
References
- 1 Christiansen SC, Cannegieter SC, Koster T. et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. J Am Med Assoc 2005; 293: 2352-2361.
- 2 Baglin T. Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet. J Thromb Haemost 2006; 4: 2530-2532.
- 3 Palareti G, Legnani C, Cosmi B. et al. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. J Thromb Haemost 2005; 3: 955-961.
- 4 Prandoni P, Hutten BA, van Dongen CJ. et al. Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep venous thrombosis. J Thromb Haemost. 2007 Epub ahead of print.
- 5 Gadisseur AP, Christiansen SC, van der Meer FJ. et al. The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study (LETS). J Thromb Haemost 2007; 5: 931-936.
- 6 Italian Federation of Anticoagulation Clinics.. A guide to Oral Anticoagulant Therapy. Haemostasis 1998; 28 (Suppl. 01) 1-46.
- 7 Buller HR, Agnelli G, Hull RD. et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-428S.
- 8 Mariani G, Manotti C, Dettori AG. A computerized regulation of dosage in oral anticoagulant therapy. Res Clin Lab 1990; 20: 119-125.
- 9 Rosendaal FR, Cannegieter SC, van der Meer FJM. et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
- 10 Poli D, Antonucci E, Cecchi E. et al. Clotting activation after oral anticoagulant therapy discontinuation: a risk factor for recurrent venous thromboembolism. Blood Coagul Fibrinolysis 2004; 15: 221-225.